Potentials our cell therapy technologies using Japanese biomaterials for future collaboration between Japan and overseas partners for commercialization and further research.
For details please see the cover story of Eurobiz July.

Potentials our cell therapy technologies using Japanese biomaterials for future collaboration between Japan and overseas partners for commercialization and further research.
For details please see the cover story of Eurobiz July.
Reported by Dr. Akio Horiguchi at IMORU, 2025 at Hamburg, Germany 07 Apr 2025 The Bees-Haus method (Buccal epi
Published in Nature Scientific Reports 01 Mar 2025 neu REFIX® exo-polysaccharide Beta glucan improves Dystroph
Sri Ramachandra Institute team triumphs in the FCQ of NCRM NICHE 2024 02 Dec 2024 Winners of the XIX Fujio Cup
A global recognition to our 16-year long research outcome! 30 Nov 2024 In the Genito-Urinary Reconstructive Su
At International Conference in Yokohama, Japan 17 Aug 2024 Nichi BRITE Beta glucan administration resulted in
At the MENA Conference on Rare DiData presented in IFPA 7th World Psoriasis conference, in Stockholm, Sweden 0
Cliny PEG Gastrostomy kits of Create Medic launched in India by Medinippon, GNCorp sister company 11Aug2023 Ja
Japanese scientists, research collaborators to Nichi-in Centre for Regenerative Medicine (NCRM) have reported an increased yield of Beta 1,3-1,6 glucans in the produc